DK149092C - Analogifremgangsmaade til fremstilling af tripeptider eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af tripeptider eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number
DK149092C
DK149092C DK109280A DK109280A DK149092C DK 149092 C DK149092 C DK 149092C DK 109280 A DK109280 A DK 109280A DK 109280 A DK109280 A DK 109280A DK 149092 C DK149092 C DK 149092C
Authority
DK
Denmark
Prior art keywords
polypeptides
thr
ala
tripeptides
analogue
Prior art date
Application number
DK109280A
Other languages
Danish (da)
English (en)
Other versions
DK109280A (da
DK149092B (da
Inventor
Gideon Goldstein
George Heavner
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of DK109280A publication Critical patent/DK109280A/da
Publication of DK149092B publication Critical patent/DK149092B/da
Application granted granted Critical
Publication of DK149092C publication Critical patent/DK149092C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/18—Thymus derived hormone or factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK109280A 1979-03-14 1980-03-13 Analogifremgangsmaade til fremstilling af tripeptider eller farmaceutisk acceptable syreadditionssalte deraf DK149092C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/020,159 US4215112A (en) 1979-03-14 1979-03-14 Tripeptides and methods
US2015979 1979-03-14

Publications (3)

Publication Number Publication Date
DK109280A DK109280A (da) 1980-09-15
DK149092B DK149092B (da) 1986-01-20
DK149092C true DK149092C (da) 1986-06-16

Family

ID=21797075

Family Applications (1)

Application Number Title Priority Date Filing Date
DK109280A DK149092C (da) 1979-03-14 1980-03-13 Analogifremgangsmaade til fremstilling af tripeptider eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (18)

Country Link
US (1) US4215112A (fr)
EP (1) EP0016611B1 (fr)
JP (1) JPS55143945A (fr)
AT (1) ATE4452T1 (fr)
AU (1) AU531556B2 (fr)
CA (1) CA1141375A (fr)
DE (1) DE3064559D1 (fr)
DK (1) DK149092C (fr)
ES (1) ES8103027A1 (fr)
FI (1) FI67692C (fr)
GR (1) GR68039B (fr)
IE (1) IE49289B1 (fr)
IL (1) IL59604A (fr)
NO (1) NO149997C (fr)
NZ (1) NZ193063A (fr)
PT (1) PT70936B (fr)
YU (1) YU41914B (fr)
ZA (1) ZA801482B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369137A (en) * 1980-06-17 1983-01-18 Ortho Pharmaceutical Corporation N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide
US4298523A (en) * 1980-06-17 1981-11-03 Ortho Pharmaceutical Corporation Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
US4454065A (en) * 1982-05-18 1984-06-12 Smithkline Beckman Corporation Oligopeptide prodrugs
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
EP0215805A1 (fr) * 1985-01-18 1987-04-01 MERCK PATENT GmbH Peptides de regulation immunitaire
US4584284A (en) * 1985-01-31 1986-04-22 Ortho Pharmaceutical Corporation Bursopoietin
IT1188646B (it) * 1986-04-09 1988-01-20 Ellem Ind Farmaceutica Tripeptide ad attivita' immunostimolante
IT1196958B (it) * 1986-07-10 1988-11-25 Ellem Ind Farmaceutica Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
ATE136551T1 (de) * 1988-05-10 1996-04-15 Alpha 1 Biomedicals Inc Festphase-verfahren zur gewinnung von thymosin- alpha-1
HU201964B (en) * 1989-01-13 1991-01-28 Richter Gedeon Vegyeszet Process for producing peptides inhibiting maturation of t-lymphocytes and activity of macrophages, as well as pharmaceutical compositions comprising same
US6258932B1 (en) * 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
MXPA02001349A (es) * 1999-08-09 2002-07-22 Tripep Ab Inhibidores de la polimerizacion de proteinas y metodos de uso.
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US6455670B1 (en) * 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
EP1436317A1 (fr) * 2001-09-19 2004-07-14 Tripep Ab Molecules bloquant l'infectivite virale et methodes d'utilisation associees
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
KR20050101221A (ko) * 2003-02-21 2005-10-20 트리펩 아베 Ｈｉｖ 복제의 억제를 위한 글리신아미드 유도체

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098777A (en) * 1977-03-14 1978-07-04 Merck & Co., Inc. Process for the preparation of pyroglutamyl-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn
FR2391994A1 (fr) * 1977-05-25 1978-12-22 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese
SE446867B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
SE446866B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en aktiv polypeptid med formaga att inducera differentiering av bade t-lymfocyter och komplementreceptor (cr?72+) b-lymfocyter
NZ189101A (en) * 1977-12-08 1984-07-06 Ortho Pharma Corp Polypeptides having the ability to induce differentiation of both th-1+ t-lymphocytes and bu-1+ b-lymphocytes;pharmaceutical compositions

Also Published As

Publication number Publication date
PT70936B (en) 1981-06-24
EP0016611A3 (en) 1981-01-07
DE3064559D1 (en) 1983-09-22
ZA801482B (en) 1981-10-28
IL59604A (en) 1983-02-23
GR68039B (fr) 1981-10-27
NO800723L (no) 1980-09-15
DK109280A (da) 1980-09-15
AU531556B2 (en) 1983-08-25
FI800780A (fi) 1980-09-15
FI67692B (fi) 1985-01-31
JPS55143945A (en) 1980-11-10
DK149092B (da) 1986-01-20
PT70936A (en) 1980-04-01
ES489522A0 (es) 1981-02-16
IE49289B1 (en) 1985-09-04
NO149997B (no) 1984-04-24
IE800514L (en) 1980-09-14
NZ193063A (en) 1984-07-06
NO149997C (no) 1984-08-01
EP0016611B1 (fr) 1983-08-17
ES8103027A1 (es) 1981-02-16
YU69880A (en) 1983-02-28
EP0016611A2 (fr) 1980-10-01
FI67692C (fi) 1985-05-10
CA1141375A (fr) 1983-02-15
IL59604A0 (en) 1980-06-30
ATE4452T1 (de) 1983-09-15
YU41914B (en) 1988-02-29
US4215112A (en) 1980-07-29
AU5631280A (en) 1980-09-18

Similar Documents

Publication Publication Date Title
DK149092C (da) Analogifremgangsmaade til fremstilling af tripeptider eller farmaceutisk acceptable syreadditionssalte deraf
US4003884A (en) Peptides having LH-RH/FSH-RH activity
RU94036773A (ru) Домен i ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена i
NO932148L (no) Fusjonspolypeptider
EP0055113B1 (fr) Déca-, undéca-, dodéca et tridécapeptides ayant une activité thymique, leur méthode de préparation et les compositions les contenant
CA2157506C (fr) Oligopeptides de croissance pour l'osteogenese; compositions pharmaceutiques a base de ces produits
Yajima et al. Synthesis of the docosapeptide corresponding to the entire amino-acid sequence of porcine motilin
CA1157466A (fr) Peptides ayant des proprietes ressemblant a celles de la thymopoietine
IE782423L (en) Tetrapeptide segment
Ciardelli et al. Activity of synthetic thymosin. alpha. 1 C-terminal peptides in the azathioprine E-rosette inhibition assay
IE893110L (en) Peptides having t cell suppressor activity
FR2408581A1 (fr) Composition de pentapeptide, son procede d'obtention et composition therapeutique en comportant
Fliri et al. Cyclosporine: Synthetic studies, structure-activity relationships, biosynthesis and mode of action
Qiu-PiNG et al. Biological activity in vivo of insulin analogues modified in the N-terminal region of the B-chain
Abiko et al. Synthesis of [Phe (4F) 3] thymopoietin II and examination of its immunological effect on the impaired blastogenic response of T-lymphocytes of uremic patients
Abiko Syntheses and Structure-Activity Relationships of Thymopoietin
GB1532148A (en) 1-substituted enkepholin derivatives